HUT61017A - Process for producing 4-/3-(4-oxothiazolidinyl)/-butinylamine derivatives and pharmaceutical compositions comprising same as active ingredient - Google Patents

Process for producing 4-/3-(4-oxothiazolidinyl)/-butinylamine derivatives and pharmaceutical compositions comprising same as active ingredient

Info

Publication number
HUT61017A
HUT61017A HU911239A HU123991A HUT61017A HU T61017 A HUT61017 A HU T61017A HU 911239 A HU911239 A HU 911239A HU 123991 A HU123991 A HU 123991A HU T61017 A HUT61017 A HU T61017A
Authority
HU
Hungary
Prior art keywords
butinylamine
oxothiazolidinyl
derivatives
producing
active ingredient
Prior art date
Application number
HU911239A
Other languages
English (en)
Other versions
HU911239D0 (en
Inventor
Nicholas Joseph Hrib
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of HU911239D0 publication Critical patent/HU911239D0/hu
Publication of HUT61017A publication Critical patent/HUT61017A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HU911239A 1990-04-16 1991-04-15 Process for producing 4-/3-(4-oxothiazolidinyl)/-butinylamine derivatives and pharmaceutical compositions comprising same as active ingredient HUT61017A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/509,280 US5034392A (en) 1990-04-16 1990-04-16 4-(3-(4-oxothiazolidinyl)butynylamines

Publications (2)

Publication Number Publication Date
HU911239D0 HU911239D0 (en) 1991-10-28
HUT61017A true HUT61017A (en) 1992-11-30

Family

ID=24025983

Family Applications (1)

Application Number Title Priority Date Filing Date
HU911239A HUT61017A (en) 1990-04-16 1991-04-15 Process for producing 4-/3-(4-oxothiazolidinyl)/-butinylamine derivatives and pharmaceutical compositions comprising same as active ingredient

Country Status (26)

Country Link
US (1) US5034392A (hu)
EP (1) EP0452850B1 (hu)
JP (1) JPH07119223B2 (hu)
KR (1) KR0163598B1 (hu)
AR (1) AR248402A1 (hu)
AT (1) ATE163010T1 (hu)
AU (1) AU636972B2 (hu)
BG (1) BG60066B2 (hu)
CA (1) CA2040489C (hu)
CZ (1) CZ284447B6 (hu)
DE (1) DE69128845T2 (hu)
DK (1) DK0452850T3 (hu)
ES (1) ES2112844T3 (hu)
FI (1) FI94755C (hu)
GR (1) GR3026319T3 (hu)
HU (1) HUT61017A (hu)
IE (1) IE911257A1 (hu)
IL (1) IL97852A (hu)
MX (1) MX25359A (hu)
NO (1) NO300134B1 (hu)
NZ (1) NZ237811A (hu)
PL (1) PL165488B1 (hu)
PT (1) PT97371B (hu)
RO (1) RO108683B1 (hu)
RU (1) RU2001914C1 (hu)
ZA (1) ZA912783B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273977A (en) * 1990-11-05 1993-12-28 Warner-Lambert Company Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.

Also Published As

Publication number Publication date
NO300134B1 (no) 1997-04-14
JPH04234879A (ja) 1992-08-24
JPH07119223B2 (ja) 1995-12-20
HU911239D0 (en) 1991-10-28
KR0163598B1 (ko) 1998-12-01
PL289892A1 (en) 1992-07-27
PT97371B (pt) 1998-08-31
RO108683B1 (ro) 1994-07-29
MX25359A (es) 1994-05-31
CS9101065A2 (en) 1991-11-12
KR910018367A (ko) 1991-11-30
ATE163010T1 (de) 1998-02-15
AR248402A1 (es) 1995-08-18
NZ237811A (en) 1993-12-23
IE911257A1 (en) 1991-10-23
AU636972B2 (en) 1993-05-13
ZA912783B (en) 1991-12-24
IL97852A0 (en) 1992-06-21
RU2001914C1 (ru) 1993-10-30
EP0452850B1 (en) 1998-02-04
NO911465D0 (no) 1991-04-15
FI911783A0 (fi) 1991-04-12
NO911465L (no) 1991-10-17
DK0452850T3 (da) 1998-09-23
PT97371A (pt) 1992-01-31
ES2112844T3 (es) 1998-04-16
CZ284447B6 (cs) 1998-11-11
FI94755B (fi) 1995-07-14
AU7502891A (en) 1991-10-17
BG60066B2 (bg) 1993-09-30
FI911783A (fi) 1991-10-17
FI94755C (fi) 1995-10-25
GR3026319T3 (en) 1998-06-30
PL165488B1 (pl) 1994-12-30
IL97852A (en) 1994-11-28
EP0452850A1 (en) 1991-10-23
DE69128845T2 (de) 1998-07-09
US5034392A (en) 1991-07-23
CA2040489A1 (en) 1991-10-17
CA2040489C (en) 2003-06-10
DE69128845D1 (de) 1998-03-12

Similar Documents

Publication Publication Date Title
HUT59106A (en) Process for producing 3-amidopyrazoles and pharmaceutical compositions comprising such compounds as active ingredient
HUT61751A (en) Process for producing benzofuran derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
HUT59145A (en) Process for producing substituted azole derivatives and pharmaceutical compositions such compounds as active ingredient
HUT56270A (en) Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient
HUT51222A (en) Process for producing 9-halogen-/z/-prostaglandin derivatives and pharmaceutical compositions comprising such active ingredient
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT52089A (en) Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT48609A (en) Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient
HUT55403A (en) Process for producing modified gangliosides and their functional derivatives, as well as pharmaceutical compositions comprising such active ingredient
HUT61298A (en) Process for producing bicyclic heterocyclic compounds and pharmaceutical composition comprising same as active ingredient
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT53646A (en) Process for producing pteridin-4-(3h)-one derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
HUT64082A (en) Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient
HU895343D0 (en) Herebicidal compositions comprising thiazole derivatives as active ingredient and process for producing the active ingredients
HUT59155A (en) Process for producing corticoid-17-alkylcarbonate derivatives substituted in 17-position and pharmaceutical compositions comprising such derivatives as active ingredient
HUT56554A (en) Process for producing uracyl derivatives and herbicidal compositions comprising same as active ingredient
HUT53897A (en) Process for producing benzopyran derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT56359A (en) Process for producing leukotriene antagonist compounds and pharmaceutical compositions comprising same as active ingredient
HUT49598A (en) Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient
HUT59116A (en) Process for producing oxazole derivatives and pharmaceutical compositions comprising oxazole derivatives as active ingredient
HUT49370A (en) Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient
HUT62593A (en) Process for producing 3-deoxymannose amine derivatives and pharmaceutical compositions comprising such active ingredient
HUT58082A (en) Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds as active ingredient

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: HOECHST MARION ROUSSEL, INCORPORATED, US

DFD9 Temporary protection cancelled due to non-payment of fee